Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase - PubMed (original) (raw)

Comparative Study

Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase

C Liebow et al. Proc Natl Acad Sci U S A. 1989 Mar.

Abstract

Several analogues of somatostatin were examined in the Mia PaCa-2 human pancreatic cancer cell line for their ability to promote tyrosine phosphatase activity affecting the receptors for the epidermal growth factor. The inhibition of growth of the Mia PaCa-2 cells in culture was also evaluated to determine the mechanism of action of somatostatin analogues and their relative effectiveness in inhibiting cancer growth. Of the analogues tested D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Trp-NH2 (RC-160) caused the greatest stimulation of tyrosine phosphatase activity. Analogue D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2 (RC-121) had less effect but was more potent than somatostatin-14. Analogue D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr(ol) (SMS 201-995) produced no significant dephosphorylation. The analogues displayed the same order of activity in assays on growth inhibition of Mia PaCa-2 cells in cultures. Analogue (SMS-201-995) caused virtually no tyrosine phosphatase stimulation or growth inhibition in this cancer cell line, although it possesses a much higher antisecretory activity than somatostatin-14 in normal tissues. These observations indicate that somatostatin and some of its analogues can act as growth inhibitors in cancer cells through the activation of tyrosine phosphatase. These data reinforce the view that somatostatin analogue RC-160 and related compounds could be used for treatment of pancreatic cancer.

PubMed Disclaimer

Cited by

Identification, characterization and purification to near-homogeneity of a novel 67 kDa phosphotyrosyl protein phosphatase associated with pig lung annexin extract.
Vicendo P, Fauvel J, Ragab-Thomas JM, Chap H. Vicendo P, et al. Biochem J. 1991 Sep 1;278 ( Pt 2)(Pt 2):435-40. doi: 10.1042/bj2780435. Biochem J. 1991. PMID: 1654882 Free PMC article.
Somatostatin and somatostatin receptor physiology.
Barnett P. Barnett P. Endocrine. 2003 Apr;20(3):255-64. doi: 10.1385/ENDO:20:3:255. Endocrine. 2003. PMID: 12721505 Review.
Alterations in receptor-mediated kinases and phosphatases during carcinogenesis.
Crean DH, Liebow C, Lee MT, Kamer AR, Schally AV, Mang TS. Crean DH, et al. J Cancer Res Clin Oncol. 1995;121(3):141-9. doi: 10.1007/BF01198095. J Cancer Res Clin Oncol. 1995. PMID: 7713985
Somatostatin and Somatostatin Receptors in Tumour Biology.
Kumar U. Kumar U. Int J Mol Sci. 2023 Dec 28;25(1):436. doi: 10.3390/ijms25010436. Int J Mol Sci. 2023. PMID: 38203605 Free PMC article. Review.
Co-purification of a protein tyrosine phosphatase with activated somatostatin receptors from rat pancreatic acinar membranes.
Zeggari M, Esteve JP, Rauly I, Cambillau C, Mazarguil H, Dufresne M, Pradayrol L, Chayvialle JA, Vaysse N, Susini C. Zeggari M, et al. Biochem J. 1994 Oct 15;303 ( Pt 2)(Pt 2):441-8. doi: 10.1042/bj3030441. Biochem J. 1994. PMID: 7980402 Free PMC article.

References

1. Int J Cancer. 1977 Jan;19(1):128-35 - PubMed
1. Science. 1987 Jan 16;235(4786):305-11 - PubMed
1. J Biol Chem. 1980 Sep 25;255(18):8363-5 - PubMed
1. Cancer. 1981 Mar 15;47(6 Suppl):1640-5 - PubMed
1. Biochem Biophys Res Commun. 1981 Jul 30;101(2):517-23 - PubMed

Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase - PubMed (original) (raw)